The quality of preclinical research is key to the successful translation of new drugs to the clinic. An important driver of this quality is a healthy, meticulously managed, and accurately characterized animal colony. To achieve this requires dedication and experience, and success depends critically on state-of-the-art facilities, expertise in technologies and colony management practices, as well as comprehensive health and genetic monitoring protocols. How can researchers ensure flexible access to a reliable supply of these high-quality models? Well, there’s an art to it.
Envigo is an Indiana-based healthcare firm that offers research services such as genetic testing, surgical and tumor models for pharmaceutical and biotechnology industries.